Gwangju, South Korea

Ying Wu


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ying Wu - Innovator in Thiazolidinedione Derivatives

Introduction

Ying Wu is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thiazolidinedione derivatives.

Latest Patents

Ying Wu holds a patent for a thiazolidinedione derivative, which is described as a novel compound with various therapeutic applications. The patent outlines the use of these derivatives in preventing or treating cardiovascular diseases, gastrointestinal diseases, and renal diseases. Additionally, these compounds are beneficial for preventing hair loss, stimulating hair growth, promoting osteogenic stimulation, and aiding in wound healing. The patent emphasizes the inhibition of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), an enzyme that decomposes prostaglandins, thereby enhancing the efficacy of the treatment.

Career Highlights

Ying Wu is affiliated with the Industry-Academic Cooperation Foundation at Chosun University. His role in this institution allows him to bridge the gap between academic research and practical applications in the industry. His work has garnered attention for its potential impact on various health conditions.

Collaborations

Ying Wu has collaborated with notable colleagues, including Hoon Cho and Cheol-Hee Choi. These partnerships have contributed to the advancement of research and development in the field of pharmaceuticals.

Conclusion

Ying Wu's innovative work on thiazolidinedione derivatives showcases his commitment to advancing medical science. His contributions have the potential to improve treatment options for several diseases, highlighting the importance of research and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…